ArticleCancers2023

Measurable Residual Disease (MRD) by Flow Cytometry in Adult B-Acute Lymphoblastic Leukaemia (B-ALL) and Acute Myeloid Leukaemia (AML): Correlation with Molecular MRD Testing and Clinical Outcome at One Year.

Riana van der Linde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.